Skip to main content

Table 2 Study Objectives

From: The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial

Primary Objective Secondary objectives
Change in the LV index measured by echocardiography from baseline to follow-up Change in functional capacity (NYHA class)
  All cause mortality
  Cardiovascular death
  Hospitalization
  Revascularization procedures (emergency and elective)
  Change in B-type natriuretic peptide (BNP) level
  Change in plasma norepinephrine level
  Change in serum aldosterone level
  Change in ejection fraction
  Change in MI index (wall motion score index)
  Change in sphericity index
  Change in mitral inflow index (mitral E/A ratio, mitral deceleration time)
  Change in tissue Doppler index (mitral Ea)